top of page
SPIRIVA RESPIMAT (Tiotropium) is an inhaled medication prescribed to treat asthma or chronic obstructive pulmonary disease (COPD). Patients with these conditions may have trouble breathing because of bronchospasms, which is an abnormal tightening of the muscles of the lungs. SPIRIVA RESPIMAT works by binding to receptors on the surface of muscle cells in the lung called muscarinic-receptors. When SPIRIVA RESPIMAT binds to these receptors, it causes lung muscles to relax, causing bronchodilation and making breathing easier. Fact Table Formula C19H22BrNO4S2 License US FDA, US DailyMed Bioavailability 19.5% Legal status Rx-Only Chemical Name Tiotropium Elimination half-life 5–6 days Dosage (Strength) Respimat 2.5mcg (60 puffs/30 doses/inhaler), 18mcg (30 doses/Handihaler), 18mcg (30 doses/rotacaps) Pregnancy Not Harmful Brands Spiriva Protein binding 72% PubChem CID 5487426 MedlinePlus a604018 ChEBI 90959 ATC code R03BB04 DrugBank DB01409 KEGG D01929 Routes of administration inhalation

Spiriva (Tiotropium)

  • The SPIRIVA RESPIMAT dosage is different depending on what you are using the medication for. Asthma: Two inhalations of SPIRIVA RESPIMAT 1.25 mcg once daily, COPD: Two inhalations of SPIRIVA RESPIMAT 2.5 mcg once daily You must take the medication every day for the full effect. SPIRIVA RESPIMAT is not a rescue inhaler, and should not be used to treat acute bronchospasm.
bottom of page